JP2002523458A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523458A5
JP2002523458A5 JP2000567204A JP2000567204A JP2002523458A5 JP 2002523458 A5 JP2002523458 A5 JP 2002523458A5 JP 2000567204 A JP2000567204 A JP 2000567204A JP 2000567204 A JP2000567204 A JP 2000567204A JP 2002523458 A5 JP2002523458 A5 JP 2002523458A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
hydroxy
quaternary ammonium
ammonium salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567204A
Other languages
English (en)
Japanese (ja)
Other versions
JP4601170B2 (ja
JP2002523458A (ja
Filing date
Publication date
Priority claimed from US09/184,512 external-priority patent/US5962505A/en
Priority claimed from US09/360,074 external-priority patent/US6395757B1/en
Application filed filed Critical
Publication of JP2002523458A publication Critical patent/JP2002523458A/ja
Publication of JP2002523458A5 publication Critical patent/JP2002523458A5/ja
Application granted granted Critical
Publication of JP4601170B2 publication Critical patent/JP4601170B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000567204A 1998-08-31 1999-08-31 ヒトにおけるのぼせの処置のための方法 Expired - Lifetime JP4601170B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US9862998P 1998-08-31 1998-08-31
US60/098,629 1998-08-31
US09/184,512 US5962505A (en) 1998-08-31 1998-11-02 Method for treating hot flashes in humans
US09/184,512 1998-11-02
US09/360,074 1999-07-23
US09/360,074 US6395757B1 (en) 1998-08-31 1999-07-23 Method for treating hot flashes in humans
PCT/US1999/019693 WO2000012087A1 (en) 1998-08-31 1999-08-31 Method for treating hot flashes in humans

Publications (3)

Publication Number Publication Date
JP2002523458A JP2002523458A (ja) 2002-07-30
JP2002523458A5 true JP2002523458A5 (enExample) 2006-09-21
JP4601170B2 JP4601170B2 (ja) 2010-12-22

Family

ID=27378636

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000567204A Expired - Lifetime JP4601170B2 (ja) 1998-08-31 1999-08-31 ヒトにおけるのぼせの処置のための方法

Country Status (7)

Country Link
US (1) US6395757B1 (enExample)
EP (1) EP1123098A4 (enExample)
JP (1) JP4601170B2 (enExample)
CN (1) CN1315860A (enExample)
AU (1) AU762126B2 (enExample)
CA (1) CA2339996C (enExample)
WO (1) WO2000012087A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10136404A1 (de) * 2001-07-26 2003-02-20 Johannes Wohlrab Arzneiformulierung zur topischen Anwendung für die Therapie und Prophylaxe von Hyperhidrosis
US20050288343A1 (en) * 2004-05-19 2005-12-29 Andrew Rusowicz Process of preparing substituted carbamates and intermediates thereof
EP1861361A1 (en) * 2005-03-24 2007-12-05 Sosei R&D Ltd. Glycopyrronium salts and their therapeutic use
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
US8053004B2 (en) * 2007-10-08 2011-11-08 Starmaker Products, Llc Ointment for topical treatment of hot flashes and method of use
EP2858639B1 (en) 2012-06-08 2018-09-12 The Ohio State University Treating scar injury using tocotrienol
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
CA2902795C (en) 2013-02-28 2021-06-15 Dermira, Inc. Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
WO2015028976A2 (en) * 2013-08-30 2015-03-05 Mahesh Kandula Compounds and methods for the treatment of inflammatory diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
US3943242A (en) 1974-04-10 1976-03-09 American Cyanamid Company Deodorant composition containing a quaternary ammonium saccharinate salt
US4096254A (en) 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
US5008111A (en) 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
IL76635A0 (en) * 1984-10-11 1986-02-28 Key Pharma Physiological means of enhancing transdermal delivery of drugs
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5155045A (en) 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
US5258388A (en) 1986-03-17 1993-11-02 University Of Florida Anticholinergic compounds, compositions and methods of treatment
US5223528A (en) 1986-03-17 1993-06-29 University Of Florida Anticholinergic compounds, composititons and methods of treatment
US5462950A (en) 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
US5512555A (en) 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US5525347A (en) 1995-01-31 1996-06-11 Medical University Of South Carolina Composition and methods for treating performance anxiety
US5744463A (en) 1996-06-03 1998-04-28 Bair; Glenn O. Treatment of side effects of progestins and progesterone analogues used for birth control
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans

Similar Documents

Publication Publication Date Title
JP2008509187A5 (enExample)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2012505836A5 (enExample)
JP2018524298A5 (enExample)
JP2004509061A5 (enExample)
RU2264401C3 (ru) Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения и промежуточные вещества
JP2002520416A5 (enExample)
RU2000132188A (ru) Производные эпотилонов, их синтез и применение
JP2001526218A5 (enExample)
JP2004526745A5 (enExample)
JP2002523458A5 (enExample)
JP2005511547A5 (enExample)
JP2007507494A5 (enExample)
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
JP2003519228A5 (enExample)
JP2003503449A5 (enExample)
CA2302568A1 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
HU211666A9 (en) Antiviral compounds
CA2126118A1 (en) 5-Amino-8-Methyl-7-Pyrrolidinylquinoline-3-Carboxylic Acid Derivative
JP2005513014A5 (enExample)
RU2005122615A (ru) Соединения n-(индолэтил)циклоамина
JP2002504505A5 (enExample)
JP2002509154A5 (enExample)